T. Rowe Price Investment Management, Inc. Procept Bio Robotics Corp Transaction History
T. Rowe Price Investment Management, Inc.
- $162 Billion
- Q4 2024
A detailed history of T. Rowe Price Investment Management, Inc. transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, T. Rowe Price Investment Management, Inc. holds 985,942 shares of PRCT stock, worth $63.4 Million. This represents 0.05% of its overall portfolio holdings.
Number of Shares
985,942
Previous 1,031,727
4.44%
Holding current value
$63.4 Million
Previous $82.7 Million
3.96%
% of portfolio
0.05%
Previous 0.05%
Shares
10 transactions
Others Institutions Holding PRCT
# of Institutions
295Shares Held
41.6MCall Options Held
196KPut Options Held
141K-
Vanguard Group Inc Valley Forge, PA5.14MShares$331 Million0.01% of portfolio
-
Black Rock Inc. New York, NY3.49MShares$224 Million0.0% of portfolio
-
Alliancebernstein L.P. New York, NY1.75MShares$113 Million0.05% of portfolio
-
Wellington Management Group LLP Boston, MA1.49MShares$95.9 Million0.02% of portfolio
-
Loomis Sayles & CO L P1.21MShares$77.7 Million0.12% of portfolio
About PROCEPT BioRobotics Corp
- Ticker PRCT
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 44,592,300
- Market Cap $2.87B
- Description
- PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...